STRATA CRITICAL MEDICAL INC (SRTA) Stock Overview
USA - NASDAQ:SRTA - US0926671043 - Common Stock
SRTA Key Statistics, Chart & Performance
The current stock price of SRTA is 5.1 USD.
About SRTA
Company Profile
Serta Simmons Bedding LLC engages in the manufacture of bedding products. The company is headquartered in Doraville, Georgia. The firm owns brands, such as Serta, which has five other independent licensee, Beautyrest, Tuft & Needle and Simmons.
Company Info
STRATA CRITICAL MEDICAL INC
2451 Industry Avenue
Doraville GEORGIA US
Employees: 0
Phone: 14045345000
STRATA CRITICAL MEDICAL INC / SRTA FAQ
What is the stock price of STRATA CRITICAL MEDICAL INC today?
The current stock price of SRTA is 5.1 USD. The price decreased by -1.73% in the last trading session.
What is the ticker symbol for STRATA CRITICAL MEDICAL INC stock?
The exchange symbol of STRATA CRITICAL MEDICAL INC is SRTA and it is listed on the Nasdaq exchange.
On which exchange is SRTA stock listed?
SRTA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for STRATA CRITICAL MEDICAL INC stock?
10 analysts have analysed SRTA and the average price target is 8.5 USD. This implies a price increase of 66.67% is expected in the next year compared to the current price of 5.1. Check the STRATA CRITICAL MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
How many employees does STRATA CRITICAL MEDICAL INC have?
STRATA CRITICAL MEDICAL INC (SRTA) currently has 0 employees.
What are the support and resistance levels for STRATA CRITICAL MEDICAL INC (SRTA) stock?
STRATA CRITICAL MEDICAL INC (SRTA) has a support level at 5.09. Check the full technical report for a detailed analysis of SRTA support and resistance levels.
Is STRATA CRITICAL MEDICAL INC (SRTA) expected to grow?
The Revenue of STRATA CRITICAL MEDICAL INC (SRTA) is expected to grow by 7.33% in the next year. Check the estimates tab for more information on the SRTA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy STRATA CRITICAL MEDICAL INC (SRTA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SRTA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SRTA, evaluating the profitability, health, valuation and growth aspects
- STRATA CRITICAL MEDICAL INC (SRTA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- STRATA CRITICAL MEDICAL INC (SRTA) Sales and EPS estimates to see what analysts future expectations are.
- STRATA CRITICAL MEDICAL INC (SRTA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- STRATA CRITICAL MEDICAL INC (SRTA) Insider and Institutional Ownership to learn about the owners and their transactions.
- STRATA CRITICAL MEDICAL INC (SRTA) Stock Chart to make your own analysis
- STRATA CRITICAL MEDICAL INC (SRTA) Latest news and press-releases to stay up to date.
Does STRATA CRITICAL MEDICAL INC (SRTA) stock pay dividends?
SRTA does not pay a dividend.
When does STRATA CRITICAL MEDICAL INC (SRTA) report earnings?
STRATA CRITICAL MEDICAL INC (SRTA) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of STRATA CRITICAL MEDICAL INC (SRTA)?
STRATA CRITICAL MEDICAL INC (SRTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
SRTA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SRTA.
SRTA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SRTA. The financial health of SRTA is average, but there are quite some concerns on its profitability.
SRTA Financial Highlights
Over the last trailing twelve months SRTA reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 62.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.36% | ||
| ROE | -8.51% | ||
| Debt/Equity | 0 |
SRTA Forecast & Estimates
10 analysts have analysed SRTA and the average price target is 8.5 USD. This implies a price increase of 66.67% is expected in the next year compared to the current price of 5.1.
For the next year, analysts expect an EPS growth of 64.16% and a revenue growth 7.33% for SRTA